Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice

Abstract Despite the recent therapeutic developments for the treatment of pulmonary fibrosis, its prognosis is still not well controlled, and a novel therapeutic agent is needed. Recently, the critical role of Toll-like receptors (TLRs) in the pathophysiology of pulmonary fibrosis has been reported;...

Full description

Bibliographic Details
Main Authors: Nan Ju, Hiroki Hayashi, Munehisa Shimamura, Satoshi Baba, Shota Yoshida, Ryuichi Morishita, Hiromi Rakugi, Hironori Nakagami
Format: Article
Language:English
Published: Nature Portfolio 2022-07-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-16843-7